ARTICLE
19 March 2025

Pharma TM Articles

R
Rouse

Contributor

Rouse is an IP services business focused on emerging markets. We operate as a closely integrated network to provide the full range of intellectual property services, from patent and trade mark protection and management to commercialisation, global enforcement and anti-counterfeiting.
A range of articles from Rouse since 2018 covering IP legal developments impacting the pharmaceutical industry...
United Kingdom Food, Drugs, Healthcare, Life Sciences

A range of articles from Rouse since 2018 covering IP legal developments impacting the pharmaceutical industry:

Rouse - Cambodia: Anti counterfeiting industry activity in Cambodia

Rouse - Indonesia compulsory licensing scare

Rouse - Pharma boss arrested for allegedly selling 'deadly' counterfeit drugs

Rouse - The trade in fakes from and through Southeast Asia

Rouse - Online e-commerce platform medicine sales halted in Philippines

Rouse - New product labelling rules in Indonesia

Rouse - Pharma and consumer health product counterfeiting across South East Asia

Rouse - Thailand invalidates all cannabis patents

Rouse - Vaccines and IP in Southeast Asia

Rouse - Safeguarding the intellectual property of European SMEs

Rouse - Phase 1 of China & USA Trade Agreement: Pharmaceutical related IP issues

Rouse - Fake medicines in Southeast Asia

Rouse - Data Exclusivity in Drug Manufacturing in ASEAN

The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.

Mondaq uses cookies on this website. By using our website you agree to our use of cookies as set out in our Privacy Policy.

Learn More